Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
03 2021
Historique:
received: 15 08 2020
revised: 13 10 2020
accepted: 14 10 2020
pubmed: 22 10 2020
medline: 13 8 2021
entrez: 21 10 2020
Statut: ppublish

Résumé

Mutations in TUBB4A are associated with a wide phenotypic spectrum including generalized dystonia with whispering dysphonia (DYT-TUBB4A). We report the case of a 44-year-old patient with DYT-TUBB4A with a clinical presentation of disabling progressive dystonia, with a prominent laryngeal, cervical and facial involvement. Bipallidal deep brain stimulation (DBS) resulted in a 55% reduction of dystonia severity assessed by the Burke-Fahn-Marsden scale score 6 months after surgery. The effect was obvious on the cervical and facial components of dystonia. We suggest that bipallidal DBS should be considered in patients with disabling dystonia related to TUBB4A variants.

Sections du résumé

BACKGROUND
Mutations in TUBB4A are associated with a wide phenotypic spectrum including generalized dystonia with whispering dysphonia (DYT-TUBB4A).
METHODS
We report the case of a 44-year-old patient with DYT-TUBB4A with a clinical presentation of disabling progressive dystonia, with a prominent laryngeal, cervical and facial involvement.
RESULTS
Bipallidal deep brain stimulation (DBS) resulted in a 55% reduction of dystonia severity assessed by the Burke-Fahn-Marsden scale score 6 months after surgery. The effect was obvious on the cervical and facial components of dystonia.
CONCLUSION
We suggest that bipallidal DBS should be considered in patients with disabling dystonia related to TUBB4A variants.

Identifiants

pubmed: 33084096
doi: 10.1111/ene.14602
doi:

Substances chimiques

TUBB4A protein, human 0
Tubulin 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1082-1083

Informations de copyright

© 2020 European Academy of Neurology.

Références

Lohmann K, Wilcox RA, Winkler S, et al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene: TUBB4 and DYT4 Dystonia. Ann Neurol. 2013;73:537-545.
Simons C, Wolf NI, McNeil N, et al. A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet. 2013;92:767-773.
Parker N. Hereditary whispering dysphonia. J Neurol Neurosurg Psychiatry. 1985;48:218-224.
Reese R, Volkmann J. Deep brain stimulation for the dystonias: evidence, knowledge gaps, and practical considerations. Mov Disord Clin Pract. 2017;4:486-494.
Erro R, Hersheson J, Ganos C, et al. H-ABC syndrome and DYT4: variable expressivity or pleiotropy of TUBB4 mutations? Mov Disord. 2015;30:828-833.
Curiel J, Rodríguez Bey G, Takanohashi A, et al. TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes. Hum Mol Genet. 2017;26:4506-4518.

Auteurs

Cécile Delorme (C)

Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, Institut du Cerveau et de la Moëlle Epinière, Paris, France.

Emmanuel Roze (E)

Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, Institut du Cerveau et de la Moëlle Epinière, Paris, France.

Carine Karachi (C)

Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, Institut du Cerveau et de la Moëlle Epinière, Paris, France.
Service de Neurochirurgie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.

Marie Vidailhet (M)

Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, Institut du Cerveau et de la Moëlle Epinière, Paris, France.

Elodie Hainque (E)

Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, Institut du Cerveau et de la Moëlle Epinière, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH